![](https://healthed-prod.kiratech.com.auwp-content/uploads/2020/05/ian-frazer-1.jpg")
This week’s expert: Prof Ian Frazer, Clinical Immunologist; Researcher for Vaccine Development, Faculty of Medicine, The University of QLD.
Drawn from an interview with Clinical Immunologist Prof Ian Frazer by Dr Harry Nespolon on the Healthed podcast Going Viral.
• Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.
• The major challenge exists because SARS-CoV-2 affects the respiratory tract, where the immune system is distinct from the rest of the body. Currently the problem is that we are trying to get a vaccine that is delivered systemically to specifically and significantly affect the immune system in the respiratory tract.
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
